US37611X1000
Ginkgo Bioworks Holdings, Inc.
Could not find a ticker for this position, may be a filing error
A maker of cell-engineering tools, Ginkgo Bioworks designs custom organisms and cells for pharmaceutical, agricultural, and industrial clients, using lab automation and AI models. Its Canopy and Horizon biosecurity platforms monitor wastewater and other samples for government customers to spot emerging biological threats. Founded in 2008 by five MIT scientists who wanted to make biology easier to engineer, the company took its name from the ginkgo tree, an ancient "living fossil" unchanged for tens of millions of years.
ISIN: US37611X1000HealthcareUS2 holders
Recent Activity
2024Q4
1 sell
-20.76M shares
-20.76M shares
2024Q3
2 sells
-32.23M shares(-60.8%)
-32.23M shares(-60.8%)
-117.49M shares
-117.49M shares
2024Q2
1 buy1 sell
+2.79M shares(+5.6%)
+2.79M shares(+5.6%)
-5.92M shares(-4.8%)
-5.92M shares(-4.8%)
2024Q1
1 buy1 sell
-1.81M shares(-3.5%)
-1.81M shares(-3.5%)
+2.41M shares(+2.0%)
+2.41M shares(+2.0%)
Loading more activity...